India Panel Urges Considering Aggressive Marketing As “Irrational Use”
This article was originally published in PharmAsia News
Executive Summary
An Indian steering committee said any drug maker’s aggressive marketing should be considered irrational use subject to penalties, and it called for a permanent rule to bind the industry to ethical-behavior standards.
An Indian steering committee said any drug maker’s aggressive marketing should be considered irrational use subject to penalties, and it called for a permanent rule to bind the industry to ethical-behavior standards. The report called for a mandatory code to identify and penalize unethical drug promotions. An Indian study said the Indian market was flooded with about 90,000 formulation packs and brands. (Click here for more
)
“Government Against Unethical Promotion Of Drugs” – Times Of India (4/17/12)